Video

Psychiatry Grand Rounds: “Life stories and engagement in underserved populations: Meeting mental health and SUD needs in the community”

Denis Antoine, M.D., FAPA, FASAM, applies the Life Story Perspective to re-think approaches to mental illness and substance use disorder treatments in order to improve individual and societal outcomes.

Video

Psychedelic Treatment with Psilocybin Relieves Major Depression

Roland Griffiths, director of Johns Hopkins Center for Consciousness and Psychedelic Research, describes a milestone study showing that psilocybin relieves major depression.

Video

Psychiatry Grand Rounds: “What is COVID Depression?”

Karen Swartz, M.D. highlights key findings from national surveys.

News

Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients, Study Shows

Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers ...

News

New Research into Adolescent Depression

Johns Hopkins psychiatrists point to the need for earlier, faster-acting treatments.

News

Protective Behaviors to Avoid COVID-19 May Aggravate Symptoms of Obsessive-Compulsive Disorder and Other Conditions in Some Patients

Via two studies, Johns Hopkins psychiatrists show that patients may experience obsessive-like symptoms due to fear of contamination with the virus that causes the disease.